Nitric Oxide Produced in Response to Engagement of Beta2 Integrins on Human Neutrophils Activates the Monomeric GTPases Rap1 and Rap2 and Promotes Adhesion
Overview
Authors
Affiliations
We found that engagement of beta2 integrins on human neutrophils increased the levels of GTP-bound Rap1 and Rap2. Also, the activation of Rap1 was blocked by PP1, SU6656, LY294002, GF109203X, or BAPTA-AM, which indicates that the downstream signaling events in Rap1 activation involve Src tyrosine kinases, phosphoinositide 3-kinase, protein kinase C, and release of calcium. Surprisingly, the beta2 integrin-induced activation of Rap2 was not regulated by any of the signaling pathways mentioned above. However, we identified nitric oxide as the signaling molecule involved in beta2 integrin-induced activation of Rap1 and Rap2. This was illustrated by the fact that engagement of beta2 integrins increased the production of nitrite, a stable end-product of nitric oxide. Furthermore, pretreatment of neutrophils with Nomega-monomethyl-L-arginine, or 1400W, which are inhibitors of inducible nitric-oxide synthase, blocked beta2 integrin-induced activation of Rap1 and Rap2. Similarly, Rp-8pCPT-cGMPS, an inhibitor of cGMP-dependent serine/threonine kinases, also blunted the beta2 integrin-induced activation of Rap GTPases. Also nitric oxide production and its downstream activation of cGMP-dependent serine/threonine kinases were essential for proper neutrophil adhesion by beta2 integrins. Thus, we made the novel findings that beta2 integrin engagement on human neutrophils triggers production of nitric oxide and its downstream signaling is essential for activation of Rap GTPases and neutrophil adhesion.
Stimulators and activators of soluble guanylate cyclase for urogenital disorders.
Monica F, Antunes E Nat Rev Urol. 2017; 15(1):42-54.
PMID: 29133940 DOI: 10.1038/nrurol.2017.181.
Leukocyte transcellular diapedesis: Rap1b is in control.
Filippi M Tissue Barriers. 2015; 3(3):e1052185.
PMID: 26451346 PMC: 4574898. DOI: 10.1080/21688370.2015.1052185.
Deevi R, Cox O, OConnor R Neoplasia. 2014; 16(5):422-31.
PMID: 24863845 PMC: 4198691. DOI: 10.1016/j.neo.2014.04.006.
Artemenko Y, Lampert T, Devreotes P Cell Mol Life Sci. 2014; 71(19):3711-47.
PMID: 24846395 PMC: 4162842. DOI: 10.1007/s00018-014-1638-8.
Dib K, Perecko T, Jenei V, McFarlane C, Comer D, Brown V J Leukoc Biol. 2014; 96(3):411-8.
PMID: 24799603 PMC: 5395935. DOI: 10.1189/jlb.2AB0813-432RR.